ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
In the latest episode of Ticker Take on YouTube, I spoke with Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management and author of the book Dividend Investing, about how she is evaluating ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
Silver went from $30 to $121 in 12 months — then crashed 36% in a week. Now at $85, JP Morgan targets $81 avg while some ...
Discover the step-by-step creation of a stunning miniature landscape, combining detailed diorama techniques and realistic model building. Follow along as each element—road, railway, river, and ...
Nscale, an upstart cloud provider heavily backed by Nvidia whose customers include OpenAI and Microsoft, is in talks to take control of one of the largest available sites for AI data centers in the U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results